MLchartDataset catalogue

gp209-2M

Term · Oncology and biomedicine · MLC-T-ONC-003636

A peptide (short piece of protein) made from the tumor-specific antigen gp100, and used to make vaccines being studied in the treatment of melanoma.

Table 1. Record
IdentifierMLC-T-ONC-003636
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-003636",
  "term": "gp209-2M",
  "field": "Oncology and biomedicine",
  "definition": "A peptide (short piece of protein) made from the tumor-specific antigen gp100, and used to make vaccines being studied in the treatment of melanoma.",
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/gp209-2m/"
}

Record 8,148 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.